Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma
- 14 November 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (22) , 6119-6130
Abstract
There is a dearth of knowledge about the pathogenesis of premalignant lung lesions, especially for atypical adenomatous hyperplasia (AAH), the only known precursor for the major lung cancer subtype adenocarcinoma (LUAD). In this study, we performed deep DNA and RNA sequencing analyses of a set of AAH, LUAD, and normal tissues. Somatic BRAF variants were found in AAHs from 5 of 22 (23%) patients, 4 of 5 of whom had matched LUAD with driver EGFR mutations. KRAS mutations were present in AAHs from 4 of 22 (18%) of patients. KRAS mutations in AAH were only found in ever-smokers and were exclusive to BRAF-mutant cases. Integrative analysis revealed profiles expressed in KRAS-mutant cases (UBE2C, REL) and BRAF-mutant cases (MAX) of AAH, or common to both sets of cases (suppressed AXL). Gene sets associated with suppressed antitumor (Th1; IL12A, GZMB) and elevated protumor (CCR2, CTLA-4) immune signaling were enriched in AAH development and progression. Our results reveal potentially divergent BRAF or KRAS pathways in AAH as well as immune dysregulation in the pathogenesis of this premalignant lung lesion. Cancer Res; 77(22); 6119–30. ©2017 AACR.Keywords
All Related Versions
Funding Information
- Cancer Prevention and Research Institute of Texas (RP150079)
- NIH (R01HG005859)
This publication has 48 references indexed in Scilit:
- MYC on the Path to CancerCell, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesisNature Communications, 2012
- Immune Regulation of CancerJournal of Clinical Oncology, 2010
- Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using anIn vitroLung Carcinogenesis SystemCancer Prevention Research, 2009
- Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patientsBritish Journal of Cancer, 2008
- Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakiaMolecular Cancer, 2007
- Osteopontin Expression in Normal Skin and Non-melanoma Skin TumorsJournal of Histochemistry & Cytochemistry, 2007
- A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumorsGenes & Development, 2007
- An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphsNucleic Acids Research, 2006